Literature DB >> 26341690

[Non-invasive brain stimulation for treatment of schizophrenic psychoses].

A Hasan1, T Wobrock2,3, U Palm4, W Strube4, F Padberg4, P Falkai4, A Fallgatter5, C Plewnia5.   

Abstract

Despite many different available pharmacological and psychosocial treatment options, an optimal control of symptoms is only partly possible for most schizophrenia patients. Especially, persistent auditory hallucinations, negative symptoms and cognitive impairment are difficult to treat symptoms. Several non-invasive brain stimulation techniques are increasingly being considered as new therapeutic add on options for the management of schizophrenia, targeting these symptom domains. The technique which has been available for the longest time and that is best established in clinical care is electroconvulsive therapy (ECT). New stimulation techniques, such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) allow a more pathophysiological-based approach. This review article introduces various non-invasive brain stimulation techniques and discusses recent treatment studies on schizophrenia. In total, the novel brain stimulation techniques discussed here can be considered relevant add on therapeutic approaches for schizophrenia. In this context, the best evidence is available for the application of rTMS for the treatment of negative symptoms and persistent auditory hallucinations; however, negative studies have also been published for both indications. Studies using other non-invasive brain stimulation techniques showed promising results but further research is needed to establish the clinical efficacy. Based on a growing pathophysiological knowledge, non-invasive brain stimulation techniques provide new treatment perspectives for patients with schizophrenia.

Entities:  

Keywords:  Electroconvulsive therapy; Evidence-based psychiatry; Transcranial direct current stimulation; Transcranial magnetic stimulation, repetitive; Vagus nerve stimulation

Mesh:

Year:  2015        PMID: 26341690     DOI: 10.1007/s00115-015-4323-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  54 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

2.  Relief from chronic intractable auditory hallucinations after long-term bilateral theta burst stimulation.

Authors:  Mark-Christian Eberle; Dirk Wildgruber; Barbara Wasserka; Andreas J Fallgatter; Christian Plewnia
Journal:  Am J Psychiatry       Date:  2010-11       Impact factor: 18.112

3.  Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.

Authors:  Chuan Shi; Xin Yu; Eric F C Cheung; David H K Shum; Raymond C K Chan
Journal:  Psychiatry Res       Date:  2013-12-21       Impact factor: 3.222

4.  Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.

Authors:  Hermann Stefan; Gernot Kreiselmeyer; Frank Kerling; Katrin Kurzbuch; Christophe Rauch; Marcel Heers; Burkhard S Kasper; Thilo Hammen; Martina Rzonsa; Elisabeth Pauli; Jens Ellrich; Wolfgang Graf; Rüdiger Hopfengärtner
Journal:  Epilepsia       Date:  2012-05-03       Impact factor: 5.864

Review 5.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

Review 6.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

7.  Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study.

Authors:  Joachim Cordes; P Falkai; B Guse; A Hasan; T Schneider-Axmann; M Arends; G Winterer; W Wölwer; E Ben Sliman; M Ramacher; C Schmidt-Kraepelin; C Ohmann; B Langguth; M Landgrebe; P Eichhammer; E Frank; J Burger; G Hajak; M Rietschel; T Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

8.  Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study.

Authors:  Wolfgang Strube; Tilmann Bunse; Michael A Nitsche; Thomas Wobrock; Richard Aborowa; Kristina Misewitsch; Maximiliane Herrmann; Peter Falkai; Alkomiet Hasan
Journal:  Neuropsychopharmacology       Date:  2014-10-13       Impact factor: 7.853

9.  Cerebral blood flow identifies responders to transcranial magnetic stimulation in auditory verbal hallucinations.

Authors:  P Homan; J Kindler; M Hauf; D Hubl; T Dierks
Journal:  Transl Psychiatry       Date:  2012-11-20       Impact factor: 6.222

Review 10.  Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review.

Authors:  Birgit Guse; Peter Falkai; Thomas Wobrock
Journal:  J Neural Transm (Vienna)       Date:  2009-10-27       Impact factor: 3.575

View more
  3 in total

1.  [The German research network for mental disorders].

Authors:  M Bauer; T Banaschewski; A Heinz; I Kamp-Becker; A Meyer-Lindenberg; F Padberg; M A Rapp; R Rupprecht; F Schneider; T G Schulze; H-U Wittchen
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

Review 2.  [Rationality and freedom in medicine: the case of electroconvulsive therapy].

Authors:  U Wiesing; A J Fallgatter
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

Review 3.  [Transcranial electrical brain stimulation methods for treatment of negative symptoms in schizophrenia].

Authors:  Nikolas Haller; Alkomiet Hasan; Frank Padberg; Wolfgang Strube; Leandro da Costa Lane Valiengo; Andre R Brunoni; Jerome Brunelin; Ulrich Palm
Journal:  Nervenarzt       Date:  2021-01-25       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.